BioScrip, an independent national provider of infusion and home care management solutions, and Option Care, an independent provider of home infusion therapy services, completed their merger. Financial terms were not disclosed. “Today marks the beginning of an exciting new chapter as we unite two strong organizations with proud histories as market leaders. This combination enables us to reimagine the infusion care experience to unleash the full potential of high-quality care in a lower cost setting on a national scale. We are now the only independent provider focused on delivering a full spectrum of infusion therapies to patients across the country. Our deep clinical expertise, broad therapy portfolio and enhanced financial profile empower us to deliver superior outcomes and set the standard for patient care,” John Rademacher, Option Care Chief Executive Officer.